Literature DB >> 22653045

Invasive imaging of the coronary atherosclerotic plaque.

N S Van Ditzhuijzen1, H M M Van Beusekom, J M R Ligthart, E Regar.   

Abstract

Coronary atherosclerosis has a high prevalence and is known as the leading cause of death worldwide. Clinically, coronary atherosclerosis is routinely evaluated by coronary angiography, which provides a luminogram of the coronary artery and allows for recognizing lumen narrowing. However, angiography does not allow for the direct assessment of the disease process within the coronary vessel wall. Today, a number of catheter-based imaging methods can overcome this shortcoming and provide physicians with additional information on specific morphological components of atherosclerotic lesions. This article discusses the abilities of intravascular imaging techniques such as intravascular ultrasound (IVUS), IVUS-VH, iMAP, integrated backscatter-IVUS, intravascular optical coherence tomography, near-infrared spectroscopy and angioscopy, to diagnose coronary atherosclerosis and their potential to guide clinical decision making.

Entities:  

Mesh:

Year:  2012        PMID: 22653045

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN: 0026-4725            Impact factor:   1.347


  3 in total

1.  Ex-vivo Assessment of Coronary Artery Atherosclerosis by Magnetic Resonance Imaging: Correlation with Histopathology.

Authors:  Everli P S Gonçalves Gomes; Carlos Eduardo Rochitte; Clerio F Azevedo; Pedro A Lemos; Paulo Sampaio Gutierrez; Luiz Antonio M César
Journal:  Open Cardiovasc Med J       Date:  2014-04-04

2.  Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis.

Authors:  Xueqin Gao; Chaofu Ke; Haixia Liu; Wei Liu; Kang Li; Bo Yu; Meng Sun
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

3.  Clinical correlation between N-terminal pro-B-type natriuretic peptide and angiographic coronary atherosclerosis.

Authors:  Demóstenes G L Ribeiro; Ricardo P Silva; Daniella R M M Barboza; Roberto C P Lima-Júnior; Ronaldo A Ribeiro
Journal:  Clinics (Sao Paulo)       Date:  2014-06       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.